Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q0Z944 (
hemoglobin
)
63,986
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The minor hemoglobins AIa, AIb, and AIc were studied in mice with either genetic or chemically induced diabetes. Hemoglobin AIc was elevated approximately twofold in all the phenotypically diabetic mice studied (C57BL/KsJ-db/db, C57BL/KsJ-ob/ob, C57BL/6J-db/db, and alloxan- and streptozotocin-treated mice). Elevation of the
hemoglobin
AIc in C57BL/6J-db/db mice was of short duration, reflecting the transitory diabetes characteristic of these mice. The degree of increase of
hemoglobin
AIc levels was unrelated to severity of
hyperglycemia
, duration of diabetes, age of mouse, or body weight. It is not known what factor(s) dictates the steady-state concentration of
hemoglobin
AIc.
...
PMID:Increased hemoglobin AIc in diabetic mice. 12 80
Diabetes is associated with a fluctuating impairment in oxygen transport of the erythrocytes. This impairment is correlated with
hyperglycemia
by the formation of glycosylated
hemoglobin
(HbAIC) and with inhibitory factors of glycolysis i.e. hypophosphatemia and acidosis which lower the concentration of red cell 2,3-diphosphoglycerate. Diabetic angiopathy may be the ultimate result of innumerable microvascular responses to discrete hypoxic injuries associated with increased plasma permeation through the vessel walls. It is shown that two additional risk factors for atherosclerosis--smoking and hypertriglyceridemia may also lead to arterial wall hypoxia by changing the position of the oxyhemoglobin dissociation curve.
...
PMID:Diabetic vascular disease. The importance of insulin deficiency, hyperglycemia and hypophosphatemia on red cell oxygen unloading. 27 65
Use of an ion exchange chromatographic method and a colorimetric method with thiobarbituric acid showed that levels of nonenzymatically glucosylated serum albumin were increased in patients with poorly controlled diabetes mellitus compared to controls. The two methods correlated well (r = 0.99) and clearly discriminated between normal and poorly controlled diabetic populations. The levels of glycosylated
hemoglobin
were also measured in both populations. Several patients apparently in good control based on glycosylated
hemoglobin
measurements were found to have increased levels of glycosylated albumin. Because albumin has a shorter circulating half-life than does the human erythrocyte, the plasma concentration of glucosylated albumin should be expected to reflect short-term control of
hyperglycemia
in diabetes. The studies reported here suggest that the level of glucosylated albumin may indeed be a sensitive indicator of moderate
hyperglycemia
and of early glucose intolerance.
...
PMID:Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. 29 61
The metabolic and hormonal adaptation of the maternal organism in pregnancy, the glucose dependency of the fetus, the adaptation of the fetus to the pregnancy and the clinical consequences of the adaptation are important aspects of pregnancy in diabetics.
Hyperglycemia
in the mother possibly leads to a fetal anoxia by reducing the oxygen in the maternal
hemoglobin
and at the same time to a
hyperglycemia
of the fetus which causes hyperinsulinism. The consequences of hyperinsulinism are, inter alia, adiposity and respiratory insufficiency in the child due to hyaline membranes. Insulin treatment of the mother before and during pregnancy in order to normalize the blood sugar level is consequently absolutely essential to prevent such complications.
...
PMID:[Diabetes and pregnancy (author's transl)]. 40 49
The role of metabolic abnormalities in the development of diabetic neuropathy is controversial. To investigate the influence of
hyperglycemia
on nerve conduction, we studied 20 untreated maturity-onset diabetic patients and 23 normal control subjects of similar age. Nerve conduction velocity of motor (median, peroneal, and tibial) and sensory (median and sural) nerves in diabetic patients was significantly slowed and H-reflex latency time prolonged. Levels of fasting plasma glucose in diabetic subjects were correlated with slowed motor conduction velocity of the median, peroneal, and tibial nerves but not with sensory nerve conduction velocities. Levels of glycosylated
hemoglobin
, an index of long-term glycemia, were correlated with slowing of peroneal motor conduction velocity in diabetic patients. These associations could not be explained by patient age or duration of diabetes. These findings suggest that the degree of
hyperglycemia
of untreated maturity-onset diabetes contributes to the motor nerve conduction abnormalities in this disease.
...
PMID:Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin. 42 98
Fibrinogen survival and turnover were examined in 15 adult-onset diabetic patients. (125)I-labeled fibrinogen was prepared from each patient during the period of poor carbohydrate control, or hyperglycemic period, and fibrinogen survival determined. Improved control was established in each patient and during this euglycemic period, fibrinogen survival was determined simultaneously with (125)I-fibrinogen saved from the hyperglycemic period and (131)I-labeled fibrinogen prepared from the patient during the euglycemic period. The results confirm reduced fibrinogen survival in hyperglycemic diabetic patients and demonstrate reversal of the fibrinogen abnormality when euglycemia is achieved. The results of the double-label experiments in the euglycemic period suggest that the fibrinogen molecule is not altered functionally and that an abnormal plasma or vascular environment is a more likely basis for reduced fibrinogen survival during
hyperglycemia
. Electrophoretic and chromatographic experiments demonstrated no gross chemical differences between the fibrinogens prepared from the hyperglycemic and euglycemic periods and normal fibrinogen. Fibrinogen survival gave a better correlation with serial glucose measurements than with correction of
hemoglobin
A(Ic) levels indicating that the reduced fibrinogen survival noted in diabetics is a rapidly reversible phenomenon. During the hyperglycemic period, pharmacological intervention with aspirin and dipyrimadole was attempted to examine the role of platelets in reduced fibrinogen survival. No significant change in fibrinogen survival was observed. Heparin infusion during
hyperglycemia
normalized the fibrinogen kinetics of hyperglycemic diabetic patients, suggesting that reduced fibrinogen survival during
hyperglycemia
is secondary to an effect on thrombin or one of its antagonists.
...
PMID:Reduced fibrinogen survival in diabetes mellitus. A reversible phenomenon. 42 67
Hemoglobin A1c (HbA1c) is a minor component of human
hemoglobin
resulting from a non enzymatic linkage of glucose with the NH2-terminal amino acid of the beta chain of
hemoglobin
. Under normal conditions, HbA1c represent about 5% of total
hemoglobin
. The HbA1c blood concentration increases in direct proportion of the duration and degree of
hyperglycemia
. Available procedures for measuring HbA1c include column chromatography, high pressure liquid chromatography, a colorimetric procedure based on the formation of 5-hydroxymethylfurfural and isoelectrofocusing. In a group of 138 patients, we have confirmed that HbA1c provides a useful means of evaluating the degree of diabetic control: the highest values have been recorded in cases of poor control, the lowest in cases of excellent control. In the latter case, the HbA1c values recorded were not statistically different from those obtained in a control group of 92 non-diabetic subjects. The interest of evaluating this parameter in diabetes is briefly analyzed.
...
PMID:[Hemoglobin A1c and diabetes control (author's transl)]. 44 35
Intravenous administration of xylazine to beef cattle (10 animals, 0.2 mg/kg of body weight) resulted in rapid onset (less than 15 minutes) of
hyperglycemia
. Plasma glucose values increased to 195 +/- 15 mg/dl and 305 +/- 10 mg/dl at 15 minutes and 3 hours, respectively. Concomitantly, plasma insulin concentrations dropped from 23 +/- 2 microU/ml before xylazine to 5.8 +/- 0.7 microU/ml and 2.4 +/- 0.3 microU/ml at 15 minutes and 3 hours, respectively. Parallel decreases (20%) were observed for percentage of
hemoglobin
, red blood cell number, and packed cell volume. Plasma urea nitrogen was significantly (P less than 0.01) incrased within 3 hours of xylazine administration (6.7 +/- 0.9 mg/dl vs 11.4 +/- 0.7 mg/dl). Marked changes in concentrations of plasma-free fatty acids were not observed. Alternative means of anesthesia must be considered in those instances in which biopsy material is to be used for studies of carbohydrate metabolism in vitro.
...
PMID:Xylazine-induced hyperglycemia in beef cattle. 45 74
Using a cation-exchange chromatographic method, we found normal or subnormal values for glycosylated
hemoglobin
in a few diabetic patients with persistent
hyperglycemia
. Subsequent investigations revealed that these unexpected results had originated from black patients with diabetes. In view of common occurrence of abnormal hemoglobins in the Negro population, we subjected blood preparations to electrophoresis on cellulose acetate and acrylamide gel. The results have shown the presence of
hemoglobin
S or
hemoglobin
C in each patient. When allowance was made for the percentage of the abnormal hemoglobin, the "corrected values" of glycosylated
hemoglobin
increased to the diabetic range. Furthermore, the corrected values agreed well with the "expected values" calculated from a regression line correlating fasting blood glucose concentrations and proportions of glycosylated
hemoglobin
in more than 300 diabetics with no evidence of hemoglobinopathy. We conclude that in diabetic patients presenting with
hemoglobin
S or
hemoglobin
C, there is a considerable decrease in the values for glycosylated
hemoglobin
as measured by cation-exchange chromatographic methods, and that this decrease is proportional to the percentage of the abnormal hemoglobin.
...
PMID:Low proportions of glycosylated hemoglobin associated with hemoglobin S and hemoglobin C. 45 90
To estimate during which period of time the degree of diabetes control is integrated by the level of glycosylated
hemoglobin
two approachs were used. Hb-g was assayed by cellulose acetate electrophoresis in insulin-dependent diabetics and compared to the degree of control over a 3 months period. Control was evaluated by the semiquantitative urine test for sugar "Clinitest" three time a day. Hb-g correlated highly with last month glycosuria, but not as well with those of the two preceding months. These later correlation in fact reflected the stability of control over the three months. In 7 incipient insulin dependent diabetics in whom normal glycaemia was achieved abruptly and maintained for more than one month, Hb-g fell to normal within one month and therefore did not reflect the prexisting
hyperglycemia
. Hb-g integrates precisely the degree of diabetes control, but over a one month period only.
...
PMID:[Blood concentration in glycosylated hemoglobin. Index in diabetic control time (author's transl)]. 46 Nov 60
1
2
3
4
5
6
7
8
9
10
Next >>